The European Medicines Agency has taken issue with an analysis published in the British Medical Journal that questioned the growing enthusiasm for the use of observational real-world data (RWD) as a basis for regulatory, clinical and health policy decision making.
The analysis, by authors from Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) and the Belgian health...